23 Jul, 2026
According to Straits Research, the global pupillometer market size was valued at $430.33 million in 2025 and is projected to grow from $463.89 million in 2026 to $845.99 million by 2034, registering a CAGR of 7.8% during the forecast period 2026–2034.
Pupillometers are commonly used, non-invasive, portable optical scanners for evaluating pupils safely. A pupillometer, also spelled pupilometer, is a medical instrument that uses reflected light to measure the extent of the eye's pupil. Referring to certain pupillary distance (PD) measuring devices as pupilometers is incorrect. In addition to measuring pupil size, automated pupillometers can characterize the pupillary light reflex.
Globally, cataracts, age-related macular degeneration, glaucoma, and diabetic retinopathy are the leading causes of impaired vision and blindness. Lifestyle changes have led to a rise in the incidence of diseases that cause visual impairment, including diabetes and hypertension. According to a 2019 WHO report, an estimated 2.2 million people worldwide suffer from eye disorders, of which 1 million cases could have been prevented or remain undiagnosed. These statistics represent the global prevalence of eye disease and contribute to the rising demand for pupillometer devices. In addition, ophthalmic disorders, such as childhood blindness, age-related macular degeneration, trachoma, corneal opacities, and onchocerciasis, are anticipated to have the highest incidence rate during the forecast period.
Increasing government initiatives to raise awareness of visual impairments will drive market growth during the forecast period. According to the WHO, there were 180 million visually impaired individuals worldwide in 2017, of whom 40 to 45 million were blind and unable to function independently. They required social and occupational assistance. An increase in visual impairment poses a social and economic problem, particularly in developing economies where nine out of ten individuals are visually impaired.
Despite efforts to control the rising prevalence of trachoma, the primary reason for the high global burden of blindness is the growth of the general and elderly populations. It was predicted that the burden of blindness would triple worldwide by 2020, particularly in developing economies, if additional precautions were not taken. Vision 2020 is a global initiative that seeks to raise public and governmental awareness of the effects of blindness. International decision-makers and NGOs must convince the world of the need for human and financial resources to eradicate blindness. Such government initiatives are anticipated to foster market expansion.
North America is the most significant global pupillometer market shareholder and is predicted to exhibit a CAGR of 8.5% over the forecast period. North America held the largest revenue share, as its healthcare infrastructure is highly regulated and well-developed. The increasing collective efforts of key actors to enhance their product portfolios and maintain high-quality standards are anticipated to increase pupilometer demand in this region. The leading market share in the U.S. can be attributed to the expanding presence of major market participants, such as J&J Vision, NeurOptics, Inc., and Konan Medical. The presence of key actors ensures the region's rapid access to cutting-edge technologies. In addition, favorable reimbursement regulations are anticipated to stimulate market expansion further. In the U.S., approximately 84% of the population is covered by either public (26%) or private (70%) health insurance, propelling market growth.
Europe is estimated to exhibit a CAGR of 8.7% over the forecast period. Europe's demand for pupillometers is anticipated to increase as the prevalence of vision problems rises. According to the Euro Blind Organization (EBU), approximately 1 in 30 Europeans experience vision loss annually on average. In the European region, the pupillometer's use has been facilitated by a developed healthcare infrastructure and favorable reimbursement scenarios. According to the European External Action Service (EEAS), the European government invested approximately USD 4.7 million in FY 2016 to improve healthcare infrastructure. In addition, Germany dominated the market in the region. The high prevalence of vision disorders in Germany has increased the demand for pupilometer devices. It has been a vital location for developing, producing, and selling pupillometers.
sales@straitsresearch.com